Deborah Birx, a director of Theravance, recently acquired 17,482 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on May 14, 2021. Birx now owns 29,842 shares of the company. Birx operates out of Burlingame, CA. Some additional info was provided as follows:
The Reporting Person was granted restricted stock units ("RSUs") upon the conclusion of the Issuer's 2021 annual meeting of stockholders. 100% of the RSUs will vest at the sooner of the next annual stockholder meeting or the one-year anniversary of grant, subject to the Reporting Person's continuous service as an Outside Director through the applicable vesting date.
The above information was d isclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Theravance makes a similar move, sign up!
Other recent filings from the company include the following:
OrbiMed Genesis GP LLC just provided an update on activist position in Theravance - Oct. 19, 2021
James just provided an update on activist position in Theravance - Oct. 18, 2021
Major owner of Theravance just declared 0 ownership of the company. - Oct. 15, 2021
Major owner of Theravance just picked up 1,615,427 shares - Oct. 15, 2021
Theravance's See Remarks just picked up 625 shares - Oct. 14, 2021